Gsk Plc-spon Adr. Earnings

Gsk Plc-spon Adr.’s revenue jumped 2.08% since last year same period to $7516Mn in the Q1 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated -7.4% fall in its revenue since last 3-months.

Gsk Plc-spon Adr.’s net profit jumped 55.26% since last year same period to $1624Mn in the Q1 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 292.27% jump in its net profits since last 3-months.

Gsk Plc-spon Adr.’s net profit margin jumped 52.1% since last year same period to 21.61% in the Q1 2025. On a quarterly growth basis, Gsk Plc-spon Adr. has generated 323.64% jump in its net profit margins since last 3-months.

Gsk Plc-spon Adr.’s price-to-earnings ratio after this Q1 2025 earnings stands at 18.49.

Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current quarter stand at 1.33 - a 15.65% jump from last quarter’s estimates.

Gsk Plc-spon Adr.’s earning per share (EPS) estimates for the current year stand at 1.33.

Gsk Plc-spon Adr.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Gsk Plc-spon Adr. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.